- 2024-08-28
-
NOF to Participate in RNA Leaders USA Congress on Sept 4 and 5, 2024
NOF CORPORATION is pleased to announce its participation in the upcoming RNA Leaders USA Congress, which will be held at the San Diego Convention Center, USA on September 4th and 5th, 2024. As part of the event, NOF CORPORATION will showcase its products for the Drug Delivery System at Booth #8 on September 4th and […]
- 2024-08-23
-
NOF to Exhibit at CPHI Milan from 08 – 10 Oct 2024
NOF CORPORATION is pleased to announce its participation in the upcoming CPHI Milan, which will be held at Fiera Milano, Italy from 8th to 10th October 2024. In the event, NOF CORPORATION will showcase its products for Drug Delivery System at booth #6D67, which include: SS-cleavable and pH-responsive lipids for nucleic acids/gene delivery and vaccines […]
- 2024-08-02
-
Notice of Website Maintenance (8/19)
Due to system maintenance, this site will be temporarily unavailable on Monday, August 19, 1:30PM – 2:30PM (Japan Standard Time). We apologize for any inconvenience this may cause and thank you for your understanding.
- 2024-07-25
-
NOF to Sponsor Vaccines & Immunotherapies Online Symposium on 26 Sept 2024
NOF CORPORATION is pleased to announce its sponsor and participation in the upcoming Vaccines & Immunotherapies Online Symposium on 26th September 2024. In the symposium, NOF CORPORATION will showcase its latest technologies and products for Drug Delivery System, which include: SS-cleavable and pH-responsive lipids for nucleic acids/gene delivery and vaccines Novel lipids and cationic lipids […]
- 2024-07-17
-
NOF to Participate in mRNA-Based Therapeutics Summit 2024 from Jul. 29 – 31
NOF CORPORATION is pleased to announce its participation in the upcoming 4th Annual mRNA-Based Therapeutics Summit to be held from July 29th to 31st at The Westin Boston Seaport District, Boston, USA. As part of the event, NOF CORPORATION will showcase its products for the Drug Delivery System at Booth #29 on July 30th and […]
- 2024-05-31
-
NOF to Exhibits at CPHI China 2024 from Jun. 19 – 21
NOF CORPORATION is pleased to announce that we will participate in the upcoming CPHI China to be held at Shanghai New International Expo Center, China from June 19th to 21st, 2024. In the event, NOF CORPORATION will showcase its major products for Drug Delivery System at booth #E1G36, which include: Activated PEGs for PEGylation Phospholipids […]
- 2024-05-30
-
NOF to Exhibits at LIPOSOME RESEARCH DAYS 2024 from 26 – 29 Jun.
NOF CORPORATION is pleased to announce that its European branch, NOF EUROPE GmbH, will participate in the upcoming 18th LIPOSOME RESEARCH DAYS 2024 (LRDs 2024) to be held at Technology and Innovation Centre, University of Strathclyde, Glasgow, Scotland from June 26th to 29th 2024. In the event, we will showcase its latest technologies and products […]
- 2024-05-30
-
NOF to Exhibit at CRS 2024 Annual Meeting and Exposition from 08 – 12 Jul.
NOF CORPORATION is pleased to announce its participation in the upcoming CRS 2024 Annual Meeting and Exposition in Bologna, which will be held at Bologna Congress Center, Bo, Italia from 8th to 12th July 2024. In the event, NOF CORPORATION will showcase its products for Drug Delivery System at booth #46, which include: SS-cleavable and […]
- 2024-05-23
-
NOF to Participate in ISCT 2024 from May 29 – 31
NOF CORPORATION is pleased to announce its participation in the upcoming International Society for Cell & Gene Therapy Annual Meeting 2024 (ISCT 2024), which will be held at Vancouver Convention Centre, West Building, Vancouver, Canada from May 28th to June 1st. As part of the event, NOF CORPORATION will showcase its products for at Drug […]
- 2024-04-30
-
NOF CORPORATION and Phosphorex Collaborate to Supply Lipid Nanoparticle Formulations Using NOF’s Proprietary Ionizable Lipid, COATSOME® SS Series
Tokyo, Japan, Hopkinton, MA – April 30, 2024 – NOF CORPORATION announced today a collaboration with Phosphorex, an Ampersand Capital Partners company and drug delivery-focused contract development and manufacturing organization (“CDMO”), to supply lipid Nanoparticle (LNP) formulations using NOF’s proprietary ionizable lipids, COATSOME® SS Series, further enhancing its leading position in providing LNP based drug […]